Quality of life after aortic valve replacement with biological prostheses in elderly patients
<p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department o...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
D. P. Demidov [verfasserIn] D. A. Astaspov [verfasserIn] A. V. Bogachev-Prokophiev [verfasserIn] S. I. Zheleznev [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Russisch |
| Erschienen: |
2017 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Патология кровообращения и кардиохирургия - Meshalkin National Medical Research Center, 2017, 21(2017), 3, Seite 40-47 |
|---|---|
| Übergeordnetes Werk: |
volume:21 ; year:2017 ; number:3 ; pages:40-47 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.21688/1681-3472-2017-3-40-47 |
|---|
| Katalog-ID: |
DOAJ019361033 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ019361033 | ||
| 003 | DE-627 | ||
| 005 | 20230310110159.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2017 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.21688/1681-3472-2017-3-40-47 |2 doi | |
| 035 | |a (DE-627)DOAJ019361033 | ||
| 035 | |a (DE-599)DOAJc3f4f0ccbe9e44b7a48c429b31508e2e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 050 | 0 | |a RD1-811 | |
| 100 | 0 | |a D. P. Demidov |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Quality of life after aortic valve replacement with biological prostheses in elderly patients |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a <p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p< | ||
| 650 | 4 | |a аортальный порок | |
| 650 | 4 | |a протезирование аортального клапана | |
| 650 | 4 | |a биологический протез | |
| 650 | 4 | |a сердечная недостаточность | |
| 653 | 0 | |a Surgery | |
| 700 | 0 | |a D. A. Astaspov |e verfasserin |4 aut | |
| 700 | 0 | |a A. V. Bogachev-Prokophiev |e verfasserin |4 aut | |
| 700 | 0 | |a S. I. Zheleznev |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Патология кровообращения и кардиохирургия |d Meshalkin National Medical Research Center, 2017 |g 21(2017), 3, Seite 40-47 |w (DE-627)1760607827 |x 25003119 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2017 |g number:3 |g pages:40-47 |
| 856 | 4 | 0 | |u https://doi.org/10.21688/1681-3472-2017-3-40-47 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/c3f4f0ccbe9e44b7a48c429b31508e2e |z kostenfrei |
| 856 | 4 | 0 | |u http://journalmeshalkin.ru/index.php/heartjournal/article/view/474 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1681-3472 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2500-3119 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4322 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4324 | ||
| 912 | |a GBV_ILN_4325 | ||
| 912 | |a GBV_ILN_4338 | ||
| 912 | |a GBV_ILN_4367 | ||
| 912 | |a GBV_ILN_4700 | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2017 |e 3 |h 40-47 | ||
| author_variant |
d p d dpd d a a daa a v b p avbp s i z siz |
|---|---|
| matchkey_str |
article:25003119:2017----::ultolfatrotcavrpaeetihilgclrsh |
| hierarchy_sort_str |
2017 |
| callnumber-subject-code |
RD |
| publishDate |
2017 |
| allfields |
10.21688/1681-3472-2017-3-40-47 doi (DE-627)DOAJ019361033 (DE-599)DOAJc3f4f0ccbe9e44b7a48c429b31508e2e DE-627 ger DE-627 rakwb rus RD1-811 D. P. Demidov verfasserin aut Quality of life after aortic valve replacement with biological prostheses in elderly patients 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p< аортальный порок протезирование аортального клапана биологический протез сердечная недостаточность Surgery D. A. Astaspov verfasserin aut A. V. Bogachev-Prokophiev verfasserin aut S. I. Zheleznev verfasserin aut In Патология кровообращения и кардиохирургия Meshalkin National Medical Research Center, 2017 21(2017), 3, Seite 40-47 (DE-627)1760607827 25003119 nnns volume:21 year:2017 number:3 pages:40-47 https://doi.org/10.21688/1681-3472-2017-3-40-47 kostenfrei https://doaj.org/article/c3f4f0ccbe9e44b7a48c429b31508e2e kostenfrei http://journalmeshalkin.ru/index.php/heartjournal/article/view/474 kostenfrei https://doaj.org/toc/1681-3472 Journal toc kostenfrei https://doaj.org/toc/2500-3119 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 21 2017 3 40-47 |
| spelling |
10.21688/1681-3472-2017-3-40-47 doi (DE-627)DOAJ019361033 (DE-599)DOAJc3f4f0ccbe9e44b7a48c429b31508e2e DE-627 ger DE-627 rakwb rus RD1-811 D. P. Demidov verfasserin aut Quality of life after aortic valve replacement with biological prostheses in elderly patients 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p< аортальный порок протезирование аортального клапана биологический протез сердечная недостаточность Surgery D. A. Astaspov verfasserin aut A. V. Bogachev-Prokophiev verfasserin aut S. I. Zheleznev verfasserin aut In Патология кровообращения и кардиохирургия Meshalkin National Medical Research Center, 2017 21(2017), 3, Seite 40-47 (DE-627)1760607827 25003119 nnns volume:21 year:2017 number:3 pages:40-47 https://doi.org/10.21688/1681-3472-2017-3-40-47 kostenfrei https://doaj.org/article/c3f4f0ccbe9e44b7a48c429b31508e2e kostenfrei http://journalmeshalkin.ru/index.php/heartjournal/article/view/474 kostenfrei https://doaj.org/toc/1681-3472 Journal toc kostenfrei https://doaj.org/toc/2500-3119 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 21 2017 3 40-47 |
| allfields_unstemmed |
10.21688/1681-3472-2017-3-40-47 doi (DE-627)DOAJ019361033 (DE-599)DOAJc3f4f0ccbe9e44b7a48c429b31508e2e DE-627 ger DE-627 rakwb rus RD1-811 D. P. Demidov verfasserin aut Quality of life after aortic valve replacement with biological prostheses in elderly patients 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p< аортальный порок протезирование аортального клапана биологический протез сердечная недостаточность Surgery D. A. Astaspov verfasserin aut A. V. Bogachev-Prokophiev verfasserin aut S. I. Zheleznev verfasserin aut In Патология кровообращения и кардиохирургия Meshalkin National Medical Research Center, 2017 21(2017), 3, Seite 40-47 (DE-627)1760607827 25003119 nnns volume:21 year:2017 number:3 pages:40-47 https://doi.org/10.21688/1681-3472-2017-3-40-47 kostenfrei https://doaj.org/article/c3f4f0ccbe9e44b7a48c429b31508e2e kostenfrei http://journalmeshalkin.ru/index.php/heartjournal/article/view/474 kostenfrei https://doaj.org/toc/1681-3472 Journal toc kostenfrei https://doaj.org/toc/2500-3119 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 21 2017 3 40-47 |
| allfieldsGer |
10.21688/1681-3472-2017-3-40-47 doi (DE-627)DOAJ019361033 (DE-599)DOAJc3f4f0ccbe9e44b7a48c429b31508e2e DE-627 ger DE-627 rakwb rus RD1-811 D. P. Demidov verfasserin aut Quality of life after aortic valve replacement with biological prostheses in elderly patients 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p< аортальный порок протезирование аортального клапана биологический протез сердечная недостаточность Surgery D. A. Astaspov verfasserin aut A. V. Bogachev-Prokophiev verfasserin aut S. I. Zheleznev verfasserin aut In Патология кровообращения и кардиохирургия Meshalkin National Medical Research Center, 2017 21(2017), 3, Seite 40-47 (DE-627)1760607827 25003119 nnns volume:21 year:2017 number:3 pages:40-47 https://doi.org/10.21688/1681-3472-2017-3-40-47 kostenfrei https://doaj.org/article/c3f4f0ccbe9e44b7a48c429b31508e2e kostenfrei http://journalmeshalkin.ru/index.php/heartjournal/article/view/474 kostenfrei https://doaj.org/toc/1681-3472 Journal toc kostenfrei https://doaj.org/toc/2500-3119 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 21 2017 3 40-47 |
| allfieldsSound |
10.21688/1681-3472-2017-3-40-47 doi (DE-627)DOAJ019361033 (DE-599)DOAJc3f4f0ccbe9e44b7a48c429b31508e2e DE-627 ger DE-627 rakwb rus RD1-811 D. P. Demidov verfasserin aut Quality of life after aortic valve replacement with biological prostheses in elderly patients 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p< аортальный порок протезирование аортального клапана биологический протез сердечная недостаточность Surgery D. A. Astaspov verfasserin aut A. V. Bogachev-Prokophiev verfasserin aut S. I. Zheleznev verfasserin aut In Патология кровообращения и кардиохирургия Meshalkin National Medical Research Center, 2017 21(2017), 3, Seite 40-47 (DE-627)1760607827 25003119 nnns volume:21 year:2017 number:3 pages:40-47 https://doi.org/10.21688/1681-3472-2017-3-40-47 kostenfrei https://doaj.org/article/c3f4f0ccbe9e44b7a48c429b31508e2e kostenfrei http://journalmeshalkin.ru/index.php/heartjournal/article/view/474 kostenfrei https://doaj.org/toc/1681-3472 Journal toc kostenfrei https://doaj.org/toc/2500-3119 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 21 2017 3 40-47 |
| language |
Russian |
| source |
In Патология кровообращения и кардиохирургия 21(2017), 3, Seite 40-47 volume:21 year:2017 number:3 pages:40-47 |
| sourceStr |
In Патология кровообращения и кардиохирургия 21(2017), 3, Seite 40-47 volume:21 year:2017 number:3 pages:40-47 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
аортальный порок протезирование аортального клапана биологический протез сердечная недостаточность Surgery |
| isfreeaccess_bool |
true |
| container_title |
Патология кровообращения и кардиохирургия |
| authorswithroles_txt_mv |
D. P. Demidov @@aut@@ D. A. Astaspov @@aut@@ A. V. Bogachev-Prokophiev @@aut@@ S. I. Zheleznev @@aut@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
1760607827 |
| id |
DOAJ019361033 |
| language_de |
russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ019361033</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230310110159.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2017 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21688/1681-3472-2017-3-40-47</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ019361033</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJc3f4f0ccbe9e44b7a48c429b31508e2e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD1-811</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">D. P. Demidov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Quality of life after aortic valve replacement with biological prostheses in elderly patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">аортальный порок</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">протезирование аортального клапана</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">биологический протез</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">сердечная недостаточность</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Surgery</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. A. Astaspov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. V. Bogachev-Prokophiev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. I. Zheleznev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Патология кровообращения и кардиохирургия</subfield><subfield code="d">Meshalkin National Medical Research Center, 2017</subfield><subfield code="g">21(2017), 3, Seite 40-47</subfield><subfield code="w">(DE-627)1760607827</subfield><subfield code="x">25003119</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:21</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:40-47</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21688/1681-3472-2017-3-40-47</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/c3f4f0ccbe9e44b7a48c429b31508e2e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://journalmeshalkin.ru/index.php/heartjournal/article/view/474</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1681-3472</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2500-3119</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">21</subfield><subfield code="j">2017</subfield><subfield code="e">3</subfield><subfield code="h">40-47</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
D. P. Demidov |
| spellingShingle |
D. P. Demidov misc RD1-811 misc аортальный порок misc протезирование аортального клапана misc биологический протез misc сердечная недостаточность misc Surgery Quality of life after aortic valve replacement with biological prostheses in elderly patients |
| authorStr |
D. P. Demidov |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760607827 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RD1-811 |
| illustrated |
Not Illustrated |
| issn |
25003119 |
| topic_title |
RD1-811 Quality of life after aortic valve replacement with biological prostheses in elderly patients аортальный порок протезирование аортального клапана биологический протез сердечная недостаточность |
| topic |
misc RD1-811 misc аортальный порок misc протезирование аортального клапана misc биологический протез misc сердечная недостаточность misc Surgery |
| topic_unstemmed |
misc RD1-811 misc аортальный порок misc протезирование аортального клапана misc биологический протез misc сердечная недостаточность misc Surgery |
| topic_browse |
misc RD1-811 misc аортальный порок misc протезирование аортального клапана misc биологический протез misc сердечная недостаточность misc Surgery |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Патология кровообращения и кардиохирургия |
| hierarchy_parent_id |
1760607827 |
| hierarchy_top_title |
Патология кровообращения и кардиохирургия |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760607827 |
| title |
Quality of life after aortic valve replacement with biological prostheses in elderly patients |
| ctrlnum |
(DE-627)DOAJ019361033 (DE-599)DOAJc3f4f0ccbe9e44b7a48c429b31508e2e |
| title_full |
Quality of life after aortic valve replacement with biological prostheses in elderly patients |
| author_sort |
D. P. Demidov |
| journal |
Патология кровообращения и кардиохирургия |
| journalStr |
Патология кровообращения и кардиохирургия |
| callnumber-first-code |
R |
| lang_code |
rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
txt |
| container_start_page |
40 |
| author_browse |
D. P. Demidov D. A. Astaspov A. V. Bogachev-Prokophiev S. I. Zheleznev |
| container_volume |
21 |
| class |
RD1-811 |
| format_se |
Elektronische Aufsätze |
| author-letter |
D. P. Demidov |
| doi_str_mv |
10.21688/1681-3472-2017-3-40-47 |
| author2-role |
verfasserin |
| title_sort |
quality of life after aortic valve replacement with biological prostheses in elderly patients |
| callnumber |
RD1-811 |
| title_auth |
Quality of life after aortic valve replacement with biological prostheses in elderly patients |
| abstract |
<p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p< |
| abstractGer |
<p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p< |
| abstract_unstemmed |
<p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p< |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
| container_issue |
3 |
| title_short |
Quality of life after aortic valve replacement with biological prostheses in elderly patients |
| url |
https://doi.org/10.21688/1681-3472-2017-3-40-47 https://doaj.org/article/c3f4f0ccbe9e44b7a48c429b31508e2e http://journalmeshalkin.ru/index.php/heartjournal/article/view/474 https://doaj.org/toc/1681-3472 https://doaj.org/toc/2500-3119 |
| remote_bool |
true |
| author2 |
D. A. Astaspov A. V. Bogachev-Prokophiev S. I. Zheleznev |
| author2Str |
D. A. Astaspov A. V. Bogachev-Prokophiev S. I. Zheleznev |
| ppnlink |
1760607827 |
| callnumber-subject |
RD - Surgery |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.21688/1681-3472-2017-3-40-47 |
| callnumber-a |
RD1-811 |
| up_date |
2024-07-03T23:09:25.782Z |
| _version_ |
1803601225484075008 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ019361033</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230310110159.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2017 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21688/1681-3472-2017-3-40-47</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ019361033</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJc3f4f0ccbe9e44b7a48c429b31508e2e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD1-811</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">D. P. Demidov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Quality of life after aortic valve replacement with biological prostheses in elderly patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><p<<strong<Aim.</strong< The paper aims to assess the quality of life of patients subjected to aortic valve replacement with a stented/stentless biological prosthesis. <br /<<strong<Methods.</strong< The research was done at the Acquired Heart Disease Department of Meshalkin National Medical Research Center. The inclusion criteria were patient age older than 65 years and severe stenosis of the aortic valve. 114 patients were randomized 1:1 in two groups: group I patients received stentless biological prostheses, while group II patients — stented xenopericardial ones. All patients underwent aortic valve replacement under normothermic cardiopulmonary bypass. Mean follow-up was 3.9 [2.77; 4.55] years, mean age 71.5±4 (65–84) years, mean left ventricle ejection fraction 65.5 (40–86) % and mean preoperative Log.Euroscore 5.4±1.3 (1.4–12.4). The quality of life was assessed by using a standard questionnaire SF-36.<br /<<strong<Results.</strong< Peak transprosthetic gradients at 1-year follow-up amounted to 16.22±4.34 and 24.66±4.74 mm Hg for group I and group II respectively. The 5-year survival rate was 90 [81; 99] % and 96 [90; 100] % for the two groups respectively and did not differ statistically (log rank test, p = 0.226). A statistically significant improvement of quality of life among patients in both groups was observed at 1-year follow-up, as compared to the preoperative values, however, marked intergroup differences in any of the parameters were not recorded.<br /<<strong<Conclusion.</strong< The quality of life after aortic valve replacement with stented and stentless biological prostheses in elderly patients confirms clinical and functional efficiency of both methods, does not show sound advantages of any of them and improves both the physical component of health and subjective emotional level.</p<<p<Received 25 July 2017. Revised 18 August 2017. Accepted 28 August 2017.</p<<p<<strong<Funding:</strong< The study was carried out with the support of a grant of the President of the Russian Federation (МД–6967.2016.7) created to provide government assistance to the leading research centers in Russian Federation.</p<<p<<strong<Conflict of interest:</strong< The authors declare no conflict of interest.</p<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">аортальный порок</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">протезирование аортального клапана</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">биологический протез</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">сердечная недостаточность</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Surgery</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. A. Astaspov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. V. Bogachev-Prokophiev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. I. Zheleznev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Патология кровообращения и кардиохирургия</subfield><subfield code="d">Meshalkin National Medical Research Center, 2017</subfield><subfield code="g">21(2017), 3, Seite 40-47</subfield><subfield code="w">(DE-627)1760607827</subfield><subfield code="x">25003119</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:21</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:40-47</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21688/1681-3472-2017-3-40-47</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/c3f4f0ccbe9e44b7a48c429b31508e2e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://journalmeshalkin.ru/index.php/heartjournal/article/view/474</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1681-3472</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2500-3119</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">21</subfield><subfield code="j">2017</subfield><subfield code="e">3</subfield><subfield code="h">40-47</subfield></datafield></record></collection>
|
| score |
7.4005365 |